Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial DNA topoisomerase IV is a heterotetrameric type IIA topoisomerase, typically composed of two ParC and two ParE subunits, that is essential for bacterial cell division and genome stability (Source: Wikipedia, NIH). Its primary biological function is the decatenation of interlinked daughter chromosomes following DNA replication, which it achieves by creating a transient double-strand break in one DNA duplex and passing another duplex through the gate (Source: NIH, ResearchGate). The 'cleavage complex' refers to the specific intermediate state where the enzyme is covalently linked to the broken DNA strands via a phosphotyrosine bond (Source: NIH). This complex is the primary therapeutic target for fluoroquinolone antibiotics, which act as 'topoisomerase poisons' by stabilizing the complex and preventing the religation of the DNA (Source: NIH, ACS). The resulting persistence of double-strand breaks stalls replication forks and transcription machinery, triggering the bacterial SOS response and leading to rapid, irreversible cell death (Source: ResearchGate). While topoisomerase IV is a target in both Gram-positive and Gram-negative bacteria, it is often the primary target in Gram-positive species like Staphylococcus aureus and Streptococcus pneumoniae (Source: NIH, OUP).
Fluoroquinolones and other topoisomerase inhibitors bind to the interface of the topoisomerase IV–DNA complex, stabilizing the covalent enzyme-DNA intermediate (cleavage complex). This prevents the religation of the DNA strands and leads to the accumulation of lethal double-strand breaks (Source: NIH, ResearchGate).
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial DNA topoisomerase IV–DNA cleavage complex (Topo IV–DNA complex).